Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
Illumina, Inc. (NASDAQ: ILMN) today...
Read MoreIllumina, Inc. (NASDAQ: ILMN) today...
Read MoreAura Biosciences has reported positive...
Read MoreSTAIRWAY explored the extended durability...
Read MoreGV-971, a multi-targeting oligosaccharide drug...
Read MoreThe Central Board of Indirect...
Read Moreovartis announced today that it...
Read MoreShares of Natco Pharma gained...
Read MoreMayne Pharma is pleased to...
Read MoreRegeneron Pharmaceuticals Inc. (REGN) said...
Read MoreISPE announced the release of...
Read More